Koninklijke DSM NV
XBER:DSM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Koninklijke DSM NV
XBER:DSM2
|
NL |
|
G
|
Gilead Sciences Inc
XHAM:GIS
|
US |
|
Axos Financial Inc
NYSE:AX
|
US |
|
L
|
Lubelski Wegiel Bogdanka SA
XMUN:UXX
|
PL |
|
G
|
GoDaddy Inc
F:38D
|
US |
|
C
|
Conmed Corp
F:EC8
|
US |
Dividends
Dividend Yield
Koninklijke DSM NV
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Koninklijke DSM NV
DSM2 have decreased by 0%.
Payout Ratio
Koninklijke DSM NV
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for DSM2 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DSM2 Price
Koninklijke DSM NV
| Average Annual Return | 17.09% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -45% |
| Market Capitalization | 568.6m EUR |
| Shares Outstanding | 288 539 139 |
| Percentage of Shares Shorted |
N/A
|
